Management of low-stage nonseminomatous germ cell tumors of the testis.

Testicular cancer has become one of the most curable of all solid neoplasms. High cure rates associated with modern treatment regimens for low-stage testis cancer have resulted in a shift in focus toward reducing morbidity of potentially toxic treatment regimens.